123 related articles for article (PubMed ID: 9685243)
1. A new approach to the design of novel inhibitors of Na+,K+-ATPase: 17alpha-substituted seco-D 5beta-androstane as cassaine analogues.
De Munari S; Barassi P; Cerri A; Fedrizzi G; Gobbini M; Mabilia M; Melloni P
J Med Chem; 1998 Jul; 41(16):3033-40. PubMed ID: 9685243
[TBL] [Abstract][Full Text] [Related]
2. Structure-based design and synthesis of novel potent Na+,K+ -ATPase inhibitors derived from a 5alpha,14alpha-androstane scaffold as positive inotropic compounds.
De Munari S; Cerri A; Gobbini M; Almirante N; Banfi L; Carzana G; Ferrari P; Marazzi G; Micheletti R; Schiavone A; Sputore S; Torri M; Zappavigna MP; Melloni P
J Med Chem; 2003 Aug; 46(17):3644-54. PubMed ID: 12904068
[TBL] [Abstract][Full Text] [Related]
3. 17 alpha-O-(aminoalkyl)oxime derivatives of 3 beta,14 beta-dihydroxy-5 beta-androstane and 3 beta-hydroxy-14-oxoseco-D-5 beta-androstane as inhibitors of Na(+),K(+)-ATPase at the digitalis receptor.
Gobbini M; Barassi P; Cerri A; De Munari S; Fedrizzi G; Santagostino M; Schiavone A; Torri M; Melloni P
J Med Chem; 2001 Nov; 44(23):3821-30. PubMed ID: 11689068
[TBL] [Abstract][Full Text] [Related]
4. 17beta-O-Aminoalkyloximes of 5beta-androstane-3beta,14beta-diol with digitalis-like activity: synthesis, cardiotonic activity, structure-activity relationships, and molecular modeling of the Na(+),K(+)-ATPase receptor.
Cerri A; Almirante N; Barassi P; Benicchio A; Fedrizzi G; Ferrari P; Micheletti R; Quadri L; Ragg E; Rossi R; Santagostino M; Schiavone A; Serra F; Zappavigna MP; Melloni P
J Med Chem; 2000 Jun; 43(12):2332-49. PubMed ID: 10882359
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, cardiotonic activity, and structure-activity relationships of 17 beta-guanylhydrazone derivatives of 5 beta-androstane-3 beta, 14 beta-diol acting on the Na+,K(+)-ATPase receptor.
Cerri A; Serra F; Ferrari P; Folpini E; Padoani G; Melloni P
J Med Chem; 1997 Oct; 40(21):3484-8. PubMed ID: 9341924
[TBL] [Abstract][Full Text] [Related]
6. Novel analogues of Istaroxime, a potent inhibitor of Na(+),K(+)-ATPase: Synthesis, structure-activity relationship and 3D-quantitative structure-activity relationship of derivatives at position 6 on the androstane scaffold.
Gobbini M; Armaroli S; Banfi L; Benicchio A; Carzana G; Ferrari P; Giacalone G; Marazzi G; Moro B; Micheletti R; Sputore S; Torri M; Zappavigna MP; Cerri A
Bioorg Med Chem; 2010 Jun; 18(12):4275-99. PubMed ID: 20494582
[TBL] [Abstract][Full Text] [Related]
7. Effect of the digitoxigenin derivative, INCICH-D7, on Na+, K+-ATPase.
Ramirez M; Del Valle L; Sanchez-Mendoza A; Tenorio FA; Zarco G; Pastelin G
Biochem Pharmacol; 2005 Sep; 70(6):851-7. PubMed ID: 16081050
[TBL] [Abstract][Full Text] [Related]
8. Elucidation of the Na+, K+-ATPase digitalis binding site.
Keenan SM; DeLisle RK; Welsh WJ; Paula S; Ball WJ
J Mol Graph Model; 2005 Jun; 23(6):465-75. PubMed ID: 15886034
[TBL] [Abstract][Full Text] [Related]
9. Novel analogues of istaroxime, a potent inhibitor of Na+,K+-ATPase: synthesis and structure-activity relationship.
Gobbini M; Armaroli S; Banfi L; Benicchio A; Carzana G; Fedrizzi G; Ferrari P; Giacalone G; Giubileo M; Marazzi G; Micheletti R; Moro B; Pozzi M; Scotti PE; Torri M; Cerri A
J Med Chem; 2008 Aug; 51(15):4601-8. PubMed ID: 18637667
[TBL] [Abstract][Full Text] [Related]
10. Molecular modelling studies on the digitalis binding site of the Na+/K(+)-ATPase.
Höltje HD; Anzali S
Pharmazie; 1992 Sep; 47(9):691-7. PubMed ID: 1335579
[TBL] [Abstract][Full Text] [Related]
11. Simplified digitalis-like compounds acting on Na(+), K(+)-ATPase.
Cerri A; Gobbini M
J Enzyme Inhib Med Chem; 2003 Aug; 18(4):289-95. PubMed ID: 14567542
[TBL] [Abstract][Full Text] [Related]
12. Evidence for tryptophan residues in the cation transport path of the Na(+),K(+)-ATPase.
Yudowski GA; Bar Shimon M; Tal DM; González-Lebrero RM; Rossi RC; Garrahan PJ; Beaugé LA; Karlish SJ
Biochemistry; 2003 Sep; 42(34):10212-22. PubMed ID: 12939149
[TBL] [Abstract][Full Text] [Related]
13. A sensitive [Na,K]ATPase assay specific for inhibitors acting through the digitalis-binding site.
Tao QF; Soszynski PA; Hollenberg NK; Graves SW
J Cardiovasc Pharmacol; 1995 Jun; 25(6):859-63. PubMed ID: 7564329
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of novel sodium/potassium-ATPase inhibitors by virtual screening of a compound database.
Stanton DT; Ankenbauer J; Rothgeb D; Draper M; Paula S
Bioorg Med Chem; 2007 Sep; 15(18):6062-70. PubMed ID: 17618121
[TBL] [Abstract][Full Text] [Related]
15. Sodium/potassium ATPase (Na+, K+-ATPase) and ouabain/related cardiac glycosides: A new paradigm for development of anti- breast cancer drugs?
Chen JQ; Contreras RG; Wang R; Fernandez SV; Shoshani L; Russo IH; Cereijido M; Russo J
Breast Cancer Res Treat; 2006 Mar; 96(1):1-15. PubMed ID: 16322895
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and structure-activity relationships of 17beta-substituted 14beta-hydroxysteroid 3-(alpha-L-rhamnopyranoside)s: steroids that bind to the digitalis receptor.
Templeton JF; Ling Y; Marat K; LaBella FS
J Med Chem; 1997 May; 40(10):1439-46. PubMed ID: 9154966
[TBL] [Abstract][Full Text] [Related]
17. Interactions between cardiac glycosides and sodium/potassium-ATPase: three-dimensional structure-activity relationship models for ligand binding to the E2-Pi form of the enzyme versus activity inhibition.
Paula S; Tabet MR; Ball WJ
Biochemistry; 2005 Jan; 44(2):498-510. PubMed ID: 15641774
[TBL] [Abstract][Full Text] [Related]
18. A QSAR study on a series of simplified digitalis-like compounds acting on Na+,K(+)-ATPase.
Seelam J; Satuluri VS; Gupta SP; Anwer Z
Indian J Biochem Biophys; 2011 Jun; 48(3):158-63. PubMed ID: 21793306
[TBL] [Abstract][Full Text] [Related]
19. Interaction between cardiotonic steroids and Na,K-ATPase. Effects of pH and ouabain-induced changes in enzyme conformation.
Cornelius F; Mahmmoud YA
Biochemistry; 2009 Oct; 48(42):10056-65. PubMed ID: 19778013
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of panaxatriol derivatives as Na
Wu Q; Chen P; Tu G; Li M; Pan B; Guo Y; Zhai J; Fu H
Bioorg Med Chem Lett; 2018 Sep; 28(17):2885-2889. PubMed ID: 30049579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
